HARVARD BIOSCIENCE INC - 8-K Filing
Harvard Bioscience reports Q3 2026 revenue of $22.2 million, an 8% year-over-year increase. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $HBIO
More Regulatory news
- Applied Aerospace & Defense, Inc. - 10-Q Filing
- Palomar Holdings, Inc. - 8-K Filing
- UNITED GUARDIAN INC - 10-Q Filing
- Dare Bioscience, Inc. - 8-K Filing
- NEXGEL, INC. - 8-K Filing
- TEREX CORP - 8-K Filing
- Victory Capital Holdings, Inc. - 8-K Filing
- Nano Dimension Ltd. - 8-K Filing
- M-tron Industries, Inc. - 10-Q Filing
- M-tron Industries, Inc. - 8-K Filing